Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 20,755 | 23,735 | 20,591 | 20,450 | 21,774 |
| Cost of Goods | 8,511 | 9,563 | 8,570 | 8,917 | 9,590 |
| Gross Profit | 12,244 | 14,172 | 12,021 | 11,533 | 12,184 |
| Operating Expenses | 13,929 | 13,025 | 12,394 | 13,269 | 62,442 |
| Operating Income | -1,174 | 1,710 | 197 | -819 | -49,668 |
| Interest Expense | 1,728 | 2,227 | 966 | 791 | 933 |
| Other Income | -405 | -2,687 | -365 | -644 | -193 |
| Pre-tax Income | -3,307 | -3,204 | -1,134 | -2,254 | -50,794 |
| Income Tax | 117 | -357 | 97 | 28 | -454 |
| Net Income Continuous | -3,424 | -2,847 | -1,231 | -2,282 | -50,340 |
| Net Income | $-3,424 | $-2,847 | $-1,231 | $-2,282 | $-50,340 |
| EPS Basic Total Ops | -0.77 | -0.58 | -0.30 | -0.50 | -11.42 |
| EPS Basic Continuous Ops | -0.77 | -0.57 | -0.28 | -0.52 | -11.42 |
| EPS Diluted Total Ops | -0.77 | -0.58 | -0.30 | -0.50 | -11.42 |
| EPS Diluted Continuous Ops | -0.77 | -0.57 | -0.28 | -0.52 | -11.42 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -0.10 | -0.10 | -0.20 | -0.20 |
| EBITDA(a) | $622 | $3,684 | $1,878 | $1,007 | $69 |